The Current Capacity and Future Development of Economic Evaluation for Policy Decision-Making: A Survey among Researchers and Decision-Makers in Thailand. Usa Chaikledkaew1,2 Chanida Lertpitakpong2 Yot Teerawattananon2 Montarat Thavorncharoensap1,2 Viroj Tangcharoensathien 3 1Department of Phar

Patient’s perspectives can offer great insights into perceived benefits of health interventions and the challenges and obstacles encountered as a result of the healthcare system. Now at its 10th issue, the HTAsiaLink Newsletter focuses on the theme of Patient Involvement in Health Technology Assessm

Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand Jomkwan Yothasamut1, Choenkwan Putchong1, Teera Sirisamutr1, Yot Teerawattananon1, Sripen Tantivess1,2* 1Health Intervention and Technology Assessment Program, Ministry of Public Health,

The 10th HTAsiaLink Annual Conference is the first physical conference after the pandemic hit for HTAsiaLink network. Under the theme ‘The Role of HTA in the New Normal: Driving the post-COVID health systems through evidence-informed decisions,’ a broad range of discussions were sparked and would co

Abstract (provisional) Background Over the last decade, the prevalence of obesity (BMI >= 25 kg/m2) in Thailand has been rising rapidly and consistently. Estimating the cost of obesity to society is an essential step in setting priorities for research and resource use and helping improve pu

Abstract Background: Over the last decade, the prevalence of obesity (BMI ≥ 25 kg/m2) in Thailand has been rising rapidly and consistently. Estimating the cost of obesity to society is an essential step in setting priorities for research and resource use and helping improve public awareness of th

Manuel Alexander Haasis1*, Joyce Anne Ceria1, Wantanee Kulpeng2, Yot Teerawattananon2, Marissa Alejandria3 1 National Center for Pharmaceutical Access and Management (NCPAM), Department of Health, Manila, Philippines, 2 Health Intervention and Technology Assessment Program (HITAP), Department of

Abstract Background Policymakers in high-, low-, and middle-income countries alike face challenging choices about resource allocation in health. Economic evaluation can be useful in providing decision makers with the best evidence of the anticipated benefits of new investments, as well as their

As more countries provide free health care, pharmaceutical reimbursement lists are becoming a concern, especially in low- and middle-income countries. In 2007, Nepal decreed that health is a human right and began basic health coverage for a target group of the poor, destitute, elderly, and disabled.

Abstract Thailand is encountering challenges to introduce the high-cost sofosbuvir for chronic hepatitis C treatment as part of the Universal Health Care’s benefit package. This study was conducted in respond to policy demand from the Thai government to assess the value for money and budget impac